Iijima Masami — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Iijima Masami has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Masami Iijima is listed as a Director of Takeda Pharmaceutical Co Ltd according to the most recent SEC filing dated 2026-07-06. Takeda Pharmaceutical Co Ltd is a global pharmaceutical company headquartered in Japan and listed on multiple exchanges, including the U.S. SEC. The available SEC filing confirms the board role but does not provide additional biographical details such as education, career history, nationality, or prior board positions. Therefore, public information about Iijima Masami beyond the directorship is not available from the filing itself.
Role
Director
Notability
60/100
Board memberships
Takeda Pharmaceutical Co Ltd
Awards & honors
Directorship at Takeda Pharmaceutical Co Ltd (confirmed by SEC filing dated 2026-07-06)
Masami Iijima is listed as a Director of Takeda Pharmaceutical Co Ltd according to the most recent SEC filing dated 2026-07-06. Takeda Pharmaceutical Co Ltd is a global pharmaceutical company headquartered in Japan and listed on multiple exchanges, including the U.S. SEC. The available SEC filing confirms the board role but does not provide additional biographical details such …
How many SEC Form 4 filings has Iijima Masami submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Iijima Masami's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
